Atlas FDA

Simplify Cervical Artificial Disc

FDA premarket approval P200022/S003 · decided 2021-04-01

Approval details

PMA number
P200022
Supplement
S003
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Simplify Cervical Artificial Disc
Generic name
Prosthesis, intervertebral disc
Applicant
Nuvasive, Inc.
Date received
2020-10-27
Decision date
2021-04-01
Days to decision
156 days
Decision code
APPR
Product code
MJO
Advisory committee
Orthopedic
Expedited review
No
Location
San Diego, CA
Statement
Approval for Simplify® Cervical Artificial Disc that is indicated for use in skeletally mature patients for reconstruction of the disc at one or two contiguous levels from C3-C7 following discectomy for intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain, or myelopathy due to abnormality localized to the disc space and manifested by at least one of the following conditions confirmed by radiographic imaging (e.g., X-rays, computed tomography (CT), magnetic

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NuVasive AttraX Scaffold (K240507)Nuvasive, Inc.2024-03-20
NuVasive Modulus-C Interbody System (K223731)Nuvasive, Inc.2023-01-12
Simplify Disc (K211757)Nuvasive, Inc.2021-08-20
NuVasive® VersaTie™ System (K173117)Nuvasive, Inc.2017-12-07
NuVasive CoRoent System (K141665)Nuvasive, Inc.2015-03-13
NuVasive X-CORE(R) Expandable VBR System (K142205)Nuvasive, Inc.2015-02-20
NUVASIVE NVM5 SYSTEM (K141968)Nuvasive, Inc.2014-11-14
COROENT TI-C SYSTEM (K140319)Nuvasive, Inc.2014-10-09